Dronabinol is classed to be a pregnancy Group C drug, as it has not exhibited teratogenic results in animal products at doses ranging from 0.2 to 5 periods the maximum advised human dose. On the other hand, it is important to notice that pregnant clients haven't been subjected to sufficientl